Neurokinin 3 Receptor Antagonism Rapidly Improves Vasomotor Symptoms With Sustained Duration of Action
(Abstracted from Menopause 2018;25(8):862–869)
Approximately 70% of postmenopausal women experience vasomotor symptoms, and 10% describe these symptoms as intolerable. Conventional treatment of hot flashes (HFs) includes hormone therapy and other alternative treatments; however, these treatments have mixed responses, variable availability, and can be contraindicated in some women such as those with a history of breast cancer.
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: GYNECOLOGY: MENOPAUSE Source Type: research
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Men | Menopause | Neurology | OBGYN | Women